Related Experiment Video
Updated: May 29, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Episodic paralysis in a young male
Anna Claire de Lloyd1, Stephen Davies
1University of Wales College of Medicine, Department of Endocrine and Diabetes Sciences, Room 260, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK.
Thyrotoxic periodic paralysis, a rare condition causing sudden paralysis, was diagnosed in a young male with hyperthyroidism. Treatment involved beta blockers, radioactive iodine, and eventually thyroid hormone replacement, resolving paralysis episodes.
Area of Science:
- Endocrinology
- Neurology
- Internal Medicine
Background:
- Thyrotoxic periodic paralysis (TPP) is an episodic neuromuscular disorder associated with hyperthyroidism.
- It predominantly affects young men of Asian descent, presenting with acute, severe muscle weakness or paralysis.
- Diagnosis relies on identifying hyperthyroidism and excluding other causes of periodic paralysis.
Purpose of the Study:
- To present a case study of a 19-year-old Caucasian male diagnosed with thyrotoxic periodic paralysis.
- To illustrate the diagnostic process and management challenges of TPP in a non-Asian individual.
- To highlight the long-term outcome following treatment for hyperthyroidism and subsequent thyroid dysfunction.
Main Methods:
- Clinical presentation and neurological examination of a patient experiencing recurrent paralysis.
- Thyroid function tests to confirm hyperthyroidism.
- Management included beta-blockers, a block and replacement regimen, radioactive iodine therapy, and long-term thyroxine replacement.
Main Results:
- The patient, a 19-year-old Caucasian male, was diagnosed with thyrotoxic periodic paralysis.
- Initial treatment with beta-blockers and radioactive iodine therapy led to a relapse of hyperthyroidism and paralysis.
- Permanent hypothyroidism developed, successfully managed with thyroxine replacement, leading to resolution of paralysis episodes.
Conclusions:
- Thyrotoxic periodic paralysis can occur in individuals of Caucasian descent, expanding the known demographic profile.
- Management of TPP requires careful titration of therapies to control hyperthyroidism and prevent recurrent paralysis.
- Long-term thyroid hormone replacement is crucial for maintaining euthyroidism and preventing further paralytic episodes.
Related Concept Videos
Poliomyelitis
Epilepsy ll: Types
Rabies
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Tetanus

